We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

78 hedge funds and large institutions have $85.6M invested in VanEck Biotech ETF in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more call options, than puts

Call options by funds: $9.51M | Put options by funds: $4.32M

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

10% more funds holding

Funds holding: 71 → 78 (+7)

6.7% less ownership

Funds ownership: 22.25% → 15.56% (-6.7%)

28% less capital invested

Capital invested by funds: $120M → $85.6M (-$33.9M)

39% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 33

Holders
78
Holders Change
+7
Holders Change %
+9.86%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
20
Reduced
33
Closed
6
Calls
$9.51M
Puts
$4.32M
Net Calls
+$5.19M
Net Calls Change
+$2.73M

Top Buyers

Rank Fund Capital Flow
1
TH
Timber Hill
Connecticut
+$1.92M
2
ECM
Endurant Capital Management
California
+$1.74M
3
HighTower Advisors
HighTower Advisors
Illinois
+$1.14M
4
Millennium Management
Millennium Management
New York
+$757K
5
VF
Virtu Financial
New York
+$638K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$13M
2
Citigroup
Citigroup
New York
-$5.31M
3
LFM
Lumina Fund Management
New York
-$3.7M
4
LPL Financial
LPL Financial
California
-$3.61M
5
Goldman Sachs
Goldman Sachs
New York
-$3.14M

BBH Hedge Fund Activity: Q2 2016 in Review

78 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2016, worth a combined $85.6M — down 28% from $120M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BBH positions and 6 closed out — a net gain of 7 holders — while 20 added to existing stakes and 33 trimmed.

The largest buyer was Timber Hill, adding an estimated $1.92M. The largest seller was Morgan Stanley, cutting an estimated $13M.

  • 78 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2016, up from 71 in Q1 2016.
  • Funds reported $85.6M of VanEck Biotech ETF stock for Q2 2016, down 28% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q2 2016 and 6 closed out, a net change of +7 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2016 was Timber Hill, an estimated $1.92M added.
  • The largest VanEck Biotech ETF seller in Q2 2016 was Morgan Stanley, an estimated $13M sold.

Based on aggregated 13F filings for Q2 2016.